Standout Papers
- Intracellular Tumor-Associated Antigens Represent Effective Targets for Passive Immunotherapy (2012)
- Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans (2013)
- Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma (2012)
- Detection of self-reactive CD8 + T cells with an anergic phenotype in healthy individuals (2014)
Citation Impact
Citing Papers
Effector Regulatory T Cells Reflect the Equilibrium between Antitumor Immunity and Autoimmunity in Adult T-cell Leukemia
2016 StandoutNobel
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
Spatially selective depletion of tumor-associated regulatory T cells with near-infrared photoimmunotherapy
2016
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients
2023 StandoutNobel
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
2019 StandoutNobel
Phospholipid methylation controls Atg32‐mediated mitophagy and Atg8 recycling
2015 StandoutNobel
Regulatory T cells in autoimmune kidney diseases and transplantation
2023 StandoutNobel
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
2017 Standout
How chemokines organize the tumour microenvironment
2023
A view on drug resistance in cancer
2019 StandoutNature
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Clonal Deletion Prunes but Does Not Eliminate Self-Specific αβ CD8+ T Lymphocytes
2015
CD4 + T Cell Tolerance to Tissue-Restricted Self Antigens Is Mediated by Antigen-Specific Regulatory T Cells Rather Than Deletion
2015
The biology and management of non-small cell lung cancer
2018 StandoutNature
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Pancreatic cancer
2016 Standout
CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8+ T cell antitumor immunity
2023
Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity
2016 Nature
An Atlas of Human Regulatory T Helper-like Cells Reveals Features of Th2-like Tregs that Support a Tumorigenic Environment
2017
Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer
2016
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
2017 StandoutNobel
Stromal reengineering to treat pancreas cancer
2014
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
2009 Standout
The regulation of immune tolerance by FOXP3
2017
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Thymopoiesis, Regulatory T Cells, and TCRVβ Expression in Thymoma With and Without Myasthenia Gravis, and Modulatory Effects of Steroid Therapy
2007
Immune checkpoint modulation: Rational design of combination strategies
2015
Dendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: A randomized phase II study
2017
A comprehensive overview of exosomes as drug delivery vehicles — Endogenous nanocarriers for targeted cancer therapy
2014
Regulatory T cells in cancer immunotherapy
2016 StandoutNobel
Regulatory T Cells: Molecular and Cellular Basis for Immunoregulation
2017
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
NF-κB c-Rel Is Crucial for the Regulatory T Cell Immune Checkpoint in Cancer
2017
Distinct Foxp3 enhancer elements coordinate development, maintenance, and function of regulatory T cells
2021 StandoutNobel
Stem Cell-Derived Exosome in Cardiovascular Diseases: Macro Roles of Micro Particles
2018
Regulatory T cells in the treatment of disease
2018
FOXP3+ regulatory T cells in the human immune system
2010 StandoutNobel
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
Regulatory T cells in cancer immunotherapy
2014 StandoutNobel
The secret ally: immunostimulation by anticancer drugs
2012
The PI3K Pathway in Human Disease
2017 Standout
Exosomes: Therapy delivery tools and biomarkers of diseases
2017
Regulatory T Cell-Specific Epigenomic Region Variants Are a Key Determinant of Susceptibility to Common Autoimmune Diseases
2020 StandoutNobel
Molecular and cellular insights into T cell exhaustion
2015 Standout
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection
2014
The Bare Lymphocyte Syndrome and the Regulation of MHC Expression
2001
Genetic and epigenetic basis of Treg cell development and function: from a FoxP3‐centered view to an epigenome‐defined view of natural Treg cells
2014 StandoutNobel
Roles of regulatory T cells in cancer immunity
2016
Sialyl Lewis x (CD15s) identifies highly differentiated and most suppressive FOXP3 high regulatory T cells in humans
2015 StandoutNobel
Taking regulatory T cells into medicine
2021 StandoutNobel
Regulatory T Cells and Human Disease
2020 StandoutNobel
Targeting Treg cells in cancer immunotherapy
2019 StandoutNobel
ICOS+Foxp3+TILs in gastric cancer are prognostic markers and effector regulatory T cells associated withHelicobacter pylori
2016 StandoutNobel
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
The Response to Heat Shock and Oxidative Stress inSaccharomyces cerevisiae
2011
The Role of Thymomas in the Development of Myasthenia Gravis
2003
Instability of Helios-deficient Tregs is associated with conversion to a T-effector phenotype and enhanced antitumor immunity
2016
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Proenkephalin+regulatory T cells expanded by ultraviolet B exposure maintain skin homeostasis with a healing function
2020 StandoutNobel
Epigenetic conversion of conventional T cells into regulatory T cells by CD28 signal deprivation
2020 StandoutNobel
Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells
2021 StandoutNobel
Analysis of xbx genes in C. elegans
2005 StandoutNobel
A distinct subpopulation of CD25−T-follicular regulatory cells localizes in the germinal centers
2017 StandoutNobel
Cancer immunotherapy using checkpoint blockade
2018 StandoutScience
Regulatory T cells expressing abundant CTLA‐4 on the cell surface with a proliferative gene profile are key features of human head and neck cancer
2018 StandoutNobel
Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy
2020 StandoutNobel
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody
2018 StandoutNobel
Phenotypic Complexity of the Human Regulatory T Cell Compartment Revealed by Mass Cytometry
2015
Works of Yuka Maeda being referenced
Depletion of central memory CD8+ T cells might impede the antitumor therapeutic effect of Mogamulizumab
2021
Detection of self-reactive CD8 + T cells with an anergic phenotype in healthy individuals
2014 StandoutScienceNobel
Peptide Vaccine Induces Enhanced Tumor Growth Associated with Apoptosis Induction in CD8+ T Cells
2010
Regulation of Thermotolerance by Stress-Induced Transcription Factors in Saccharomyces cerevisiae
2008
Epidermal growth factor receptor localized to exosome membranes as a possible biomarker for lung cancer diagnosis.
2013
Altered T cell development in human thymoma is related to impairment of MHC class II transactivator expression induced by interferon-gamma (IFN-γ)
2000
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel